|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li PL, Zhang X, Wang LL, Du LT, Yang YM,
Li J and Wang CX: MicroRNA-218 is a prognostic indicator in
colorectal cancer and enhances 5-fluorouracil-induced apoptosis by
targeting BIRC5. Carcinogenesis. 36:1484–1493.
2015.PubMed/NCBI
|
|
3
|
Han D, Wang M, Ma N, Xu Y, Jiang Y and Gao
X: Long non-coding RNAs: Novel players in colorectal cancer. Cancer
Lett. 361:13–21. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang AD, Fan F, Camp ER, van Buren G, Liu
W, Somcio R, Gray MJ, Cheng H, Hoff PM and Ellis LM: Chronic
oxaliplatin resistance induces epithelial-to-mesenchymal transition
in colorectal cancer cell lines. Clin Cancer Res. 12:4147–4153.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Goldberg RM, Sargent DJ, Morton RF, Fuchs
CS, Ramanathan RK, Williamson SK, Findlay BP, Pitot HC and Alberts
SR: A randomized controlled trial of fluorouracil plus leucovorin,
irinotecan, and oxaliplatin combinations in patients with
previously untreated metastatic colorectal cancer. J Clin Oncol.
22:23–30. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hector S, Bolanowska-Higdon W, Zdanowicz
J, Hitt S and Pendyala L: In vitro studies on the mechanisms of
oxaliplatin resistance. Cancer Chemother Pharmacol. 48:398–406.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmad S: Platinum-DNA interactions and
subsequent cellular processes controlling sensitivity to anticancer
platinum complexes. Chem Biodivers. 7:543–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sau A, Tregno F Pellizzari, Valentino F,
Federici G and Caccuri AM: Glutathione transferases and development
of new principles to overcome drug resistance. Arch Biochem
Biophys. 500:116–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Landriscina M, Maddalena F, Laudiero G and
Esposito F: Adaptation to oxidative stress, chemoresistance, and
cell survival. Antioxid Redox Signal. 11:2701–2716. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: Role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kapranov P, Cheng J, Dike S, Nix DA,
Duttagupta R, Willingham AT, Stadler PF, Hertel J, Hackermüller J,
Hofacker IL, et al: RNA maps reveal new RNA classes and a possible
function for pervasive transcription. Science. 316:1484–1488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F
and Liu Y: TGF-β-induced upregulation of malat1 promotes
bladder cancer metastasis by associating with suz12. Clin Cancer
Res. 20:1531–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yin DD, Liu ZJ, Zhang E, Kong R, Zhang ZH
and Guo RH: Decreased expression of long non-coding RNA MEG3
affects cell proliferation and predicts a poor prognosis in
patients with colorectal cancer. Tumour Biol. 36:4851–4859. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lai Y, Xu P, Li Q, Ren D, Wang J, Xu K and
Gao W: Downregulation of long non-coding RNA ZMAT1 transcript
variant 2 predicts a poor prognosis in patients with gastric
cancer. Int J Clin Exp Pathol. 8:5556–5562. 2015.PubMed/NCBI
|
|
15
|
Yang F, Liu YH, Dong SY, Ma RM, Bhandari
A, Zhang XH and Wang OC: A novel long non-coding RNA FGF14-AS2 is
correlated with progression and prognosis in breast cancer. Biochem
Biophys Res Commun. 470:479–483. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long non-coding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mattick JS: The genetic signatures of
non-coding RNAs. PLoS Genet. 5:e10004592009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang R, Du L, Yang X, Jiang X, Duan W, Yan
S, Xie Y, Zhu Y, Wang Q, Wang L, et al: Identification of long
non-coding RNAs as potential novel diagnosis and prognosis
biomarkers in colorectal cancer. J Cancer Res Clin Oncol.
142:2291–2301. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iyer MK, Niknafs YS, Malik R, Singhal U,
Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, et
al: The landscape of long non-coding RNAs in the human
transcriptome. Nat Genet. 47:199–208. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang X, Yang X, Zhang Y, Liu X, Zheng G,
Yang Y, Wang L, Du L and Wang C: Direct serum assay for cell-free
bmi-1 mRNA and its potential diagnostic and prognostic value
for colorectal cancer. Clin Cancer Res. 21:1225–1233. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Huang S, Li Y, Zhang W, He K, Zhao
M, Lin H, Li D, Zhang H, Zheng Z, et al: Decreased expression of
LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and
EMT in colorectal cancer cells. Tumour Biol. 37:14205–14215. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Q, Dai Y, Wang F and Hou S:
Differentially expressed long non-coding RNAs and the prognostic
potential in colorectal cancer. Neoplasma. 63:977–983. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu KF, Liang WC, Feng L, Pang JX, Waye MM,
Zhang JF and Fu WM: H19 mediates methotrexate resistance in
colorectal cancer through activating Wnt/β-catenin pathway. Exp
Cell Res. 350:312–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang J, Lei ZJ, Guo Y, Wang T, Qin ZY,
Xiao HL, Fan LL, Chen DF, Bian XW, Liu J, et al: miRNA-regulated
delivery of lincRNA-p21 suppresses β-catenin signaling and
tumorigenicity of colorectal cancer stem cells. Oncotarget.
6:37852–37870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kumar MM and Goyal R: LncRNA as a
therapeutic target for angiogenesis. Curr Top Med Chem.
17:1750–1757. 2017.doi: 10.2174/1568026617666161116144744.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pfeiffer P, Qvortrup C and Eriksen JG:
Current role of antibody therapy in patients with metastatic
colorectal cancer. Oncogene. 26:3661–3678. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benetatos L, Vartholomatos G and
Hatzimichael E: MEG3 imprinted gene contribution in tumorigenesis.
Int J Cancer. 129:773–779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou Y and Klibanski A Zhangxand: MEG3
non-coding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schuster-Gossler K, Bilinski P, Sado T,
Ferguson-Smith A and Gossler A: The mouse Gtl2 gene is
differentially expressed during embryonic development, encodes
multiple alternatively spliced transcripts, and may act as an RNA.
Dev Dyn. 212:214–228. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Miyoshi N, Wagatsuma H, Wakana S,
Shiroishi T, Nomura M, Aisaka K, Kohda T, Surani MA, Kaneko-Ishino
T and Ishino F: Identification of an imprinted gene,
Meg3/Gtl2 and its human homologue MEG3, first mapped
on mouse distal chromosome 12 and human chromosome 14q. Genes
Cells. 5:211–220. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Balik V, Srovnal J, Sulla I, Kalita O,
Foltanova T, Vaverka M, Hrabalek L and Hajduch M: MEG3: A novel
long non-coding potentially tumour-suppressing RNA in meningiomas.
J Neurooncol. 112:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang P, Ren Z and Sun P: Overexpression of
the long non-coding RNA MEG3 impairs in vitro glioma cell
proliferation. J Cell Biochem. 113:1868–1874. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chak WP, Lung RW, Tong JH, Chan SY, Lun
SW, Tsao SW, Lo KW and To KF: Downregulation of long non-coding RNA
MEG3 in nasopharyngeal carcinoma. Mol Carcinog. 56:1041–1054. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Luo G, Wang M, Wu X, Tao D, Xiao X, Wang
L, Min F, Zeng F and Jiang G: Long non-coding RNA MEG3 inhibits
cell proliferation and induces apoptosis in prostate cancer. Cell
Physiol Biochem. 37:2209–2220. 2015. View Article : Google Scholar : PubMed/NCBI
|
